Role of endogenous CYP450 metabolites of arachidonic acid in maintaining the glomerular protein permeability barrier.
about
Molecular mechanisms of renal blood flow autoregulationCytochrome P450 eicosanoids in hypertension and renal diseaseThe Role of Angiotensin II in Glomerular Volume Dynamics and Podocyte Calcium Handling.Cytochrome P450 2J2: distribution, function, regulation, genetic polymorphisms and clinical significance.Temporal characterization of the development of renal injury in FHH rats and FHH.1BN congenic strains.20-HETE and EETs in diabetic nephropathy: a novel mechanistic pathwayRole of 20-HETE in the antihypertensive effect of transfer of chromosome 5 from Brown Norway to Dahl salt-sensitive rats.Identification of potential candidate genes for hypertensive nephropathy based on gene expression profile.Interaction of nitric oxide, 20-HETE, and EETs during functional hyperemia in whisker barrel cortexTransfer of the CYP4A region of chromosome 5 from Lewis to Dahl S rats attenuates renal injury.Glomerular 20-HETE, EETs, and TGF-beta1 in diabetic nephropathy.Chronic blockade of 20-HETE synthesis reduces polycystic kidney disease in an orthologous rat model of ARPKDEndothelial-specific CYP4A2 overexpression leads to renal injury and hypertension via increased production of 20-HETE.Epoxyeicosatrienoic acids: formation, metabolism and potential role in tissue physiology and pathophysiology.20-hydroxyeicosatetraeonic acid: a new target for the treatment of hypertensionEffect of Cytochrome P450 Metabolites of Arachidonic Acid in Nephrology.8,9-Epoxyeicosatrienoic acid protects the glomerular filtration barrier.Cyp2c44 epoxygenase is essential for preventing the renal sodium absorption during increasing dietary potassium intake.
P2860
Q26825286-2B270CE1-5255-4813-929B-65E776F631D6Q28252210-10FF51F0-6CF2-4006-82A6-B89667814EC3Q33671746-1C106EAE-67DD-4194-9C1D-29F14B3561E2Q34358307-6DEE7804-C628-45A5-A502-5C845F85B534Q34599851-81BF6C62-A37C-465D-8942-6283069FB836Q34924935-7D4E67F1-EEF5-4292-8E01-798AFDE8B305Q35994428-7C68BEE8-B178-435E-919D-C2F7483C679DQ36166668-92F4F52B-E455-4C6E-B6D2-E050BE6BA30BQ36844679-DDC9B19B-2262-499D-A149-597DCCCEC082Q37018428-723CF9D4-21F0-4BDB-B055-5C370C0FEE0BQ37138818-B1808C51-0EAB-48BA-8988-8193B8BAB1E9Q37138836-43BAE7BF-956C-43AA-BC8D-C95A2B1FD88AQ37417272-F463D040-F58D-4E00-BF2F-61AB4BF1DFFCQ37510865-D1594B52-1B57-4334-84D9-AD8FC5986961Q37798679-31D8315F-14E4-456B-9227-990D6FA76F6EQ39431317-76A363EE-C9AC-4FA1-863D-609104105AA0Q39516318-75EF6806-5B5A-4951-8154-78E4B2A70714Q42062684-AB029184-6EAF-438A-8164-64DA5A3BB517
P2860
Role of endogenous CYP450 metabolites of arachidonic acid in maintaining the glomerular protein permeability barrier.
description
2007 nî lūn-bûn
@nan
2007 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Role of endogenous CYP450 meta ...... protein permeability barrier.
@ast
Role of endogenous CYP450 meta ...... protein permeability barrier.
@en
type
label
Role of endogenous CYP450 meta ...... protein permeability barrier.
@ast
Role of endogenous CYP450 meta ...... protein permeability barrier.
@en
prefLabel
Role of endogenous CYP450 meta ...... protein permeability barrier.
@ast
Role of endogenous CYP450 meta ...... protein permeability barrier.
@en
P2093
P2860
P1476
Role of endogenous CYP450 meta ...... r protein permeability barrier
@en
P2093
Jan Michael Williams
Mukut Sharma
Richard J Roman
Siddam Anjaiahh
P2860
P304
P356
10.1152/AJPRENAL.00131.2007
P577
2007-05-16T00:00:00Z